hig.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Replik om nya läkemedel mot typ 2-diabetes: Viktigt att vi skaffar oss erfarenhet och kunskap
Karolinska institutet.ORCID iD: 0000-0002-5274-9748
Show others and affiliations
2008 (Swedish)In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 105, no 17-18, p. 1310, 1312-Article in journal, Letter (Refereed) Published
Place, publisher, year, edition, pages
2008. Vol. 105, no 17-18, p. 1310, 1312-
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:hig:diva-38223PubMedID: 18561535OAI: oai:DiVA.org:hig-38223DiVA, id: diva2:1646158
Note

[Reply on new drugs against type 2 diabetes: important to gain experience and knowledge]

Available from: 2013-11-22 Created: 2022-03-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

PubMed

Authority records

Sjöholm, ÅkeEriksson, Jan W

Search in DiVA

By author/editor
Sjöholm, ÅkeEriksson, Jan W
In the same journal
Läkartidningen
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 93 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard-cite-them-right
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • sv-SE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • de-DE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf